Assessment of the Tumor Vascular Effects of the Pan-vegfr Tyrosine Kinase Inhibitor Axitinib Using Dynamic Contrast-enhanced Ultrasonography (Dce-us) in Patients With Refractory Metastatic Colorectal Cancer
Latest Information Update: 18 Feb 2016
At a glance
- Drugs Axitinib (Primary)
- Indications Colorectal cancer
- Focus Pharmacokinetics
- Acronyms AXUS
Most Recent Events
- 11 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Dec 2011 New trial record